Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | NCF1 | P14598 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19105089 | 1.00 | MAOA (0.39) | MAOADYRK1AOPRK1APPNCF1 | |
| SCHEMBL31142492 | 1.00 | MAOA (0.39) | MAOADYRK1AOPRK1APPNCF1 | |
| SCHEMBL19116818 | 0.89 | NCF1 (0.45) | NCF1KDM4ERECQLTDP1MAPK1 | |
| SCHEMBL19117282 | 0.85 | NCF1 (0.34) | MAOANCF1KDM4ETDP1MAPK1 | |
| SCHEMBL11291373 | 0.80 | MAPT (0.41) | KDM4ETDP1MAPK1 | |
| SCHEMBL25336502 | 0.80 | PDE3B (0.45) | — | |
| SCHEMBL10067075 | 0.76 | PDE3B (0.35) | MAOAKDM4E | |
| SCHEMBL31142498 | 0.76 | PLA2G2A (0.39) | KDM4ERECQL | |
| Hydrochloric Acid SCHEMBL17824011 | 0.76 | EHMT2 (0.51) | NCF1KDM4ERECQLTDP1 | |
| SCHEMBL12200646 | 0.74 | PDK2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250126-A1 | Indodicarbocyanine Phosphoramidites with Bathochromically Shifted Absorption and Emission, and Tunable Hydrophobicity | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250126-A1 | Indodicarbocyanine Phosphoramidites with Bathochromically Shifted Absorption and Emission, and Tunable Hydrophobicity | NT5C3B, PCNA, POLL | MAOA 4311/4885DYRK1A 2011/4885OPRK1 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.